{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:47:23Z","timestamp":1794275243407,"version":"4.9.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Antibiotic susceptibility of <jats:italic>Helicobacter pylori<\/jats:italic> to antibiotics may vary among different niches of the stomach. The progression of chronic <jats:italic>H. pylori<\/jats:italic> gastritis to atrophy changes intragastric physiology that may influence selection of resistant strains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To study the antibiotic resistance of <jats:italic>H. pylori<\/jats:italic> taking the severity of atrophic gastritis in antrum and corpus into account.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Helicobacter pylori<\/jats:italic>-positive patients (<jats:italic>n<\/jats:italic>\u2009=\u2009110, <jats:italic>m<\/jats:italic>\u2009=\u200932, mean age 52.6\u2009\u00b1\u200913.9\u2009years) without prior <jats:italic>H. pylori<\/jats:italic> eradication undergoing upper gastrointestinal (GI) endoscopy for dyspeptic symptoms were included in a prospective study. Patients were stratified into three groups depending on the grade of atrophy: no atrophy (OLGA Stage 0), mild atrophy (OLGA Stage I\u2013II) and moderate\/severe atrophy (OLGA Stage III\u2013IV). Two biopsies each from the antrum and the corpus and one from the angulus were taken and assessed according to the updated Sydney system. <jats:italic>H. pylori<\/jats:italic> strains were isolated from antrum and corpus biopsies and tested for antibiotic susceptibility (AST) for amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and rifampicin by the agar dilution methods. A Chi-square test of independence with a 95% confidence interval was used to detect differences in the proportion of patients with susceptible and resistant <jats:italic>H. pylori<\/jats:italic> strains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 110 patients, primary clarithromycin resistance (R) was 30.0%, both in the antrum and corpus; metronidazole resistance accounted for 36.4 and 34.5% in the antrum and corpus; and levofloxacin was 19.1 and 22.7% in the antrum and corpus, respectively. Resistance rates to amoxicillin, tetracycline, and rifampicin were below 5%. Dual antibiotic resistance rate was 21.8%, and triple resistance rate was 9.1%. There was a significant difference in the resistance rate distribution in antrum (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001) and corpus (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001). With increasing severity of atrophy according to OLGA stages, there was a significant increase in clarithromycin-R and metronidazole-R.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In treatment-na\u00efve patients, antibiotic resistance and heteroresistance were related to the severity of atrophy. The high clarithromycin resistance in atrophic gastritis suggests that <jats:italic>H. pylori<\/jats:italic> antibiotic susceptibility testing should always be performed in this condition before selecting the eradication regimen.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2022.938676","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:33:43Z","timestamp":1663907623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-na\u00efve patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Elisabetta","family":"Goni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Tammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sch\u00fctte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima","family":"Thon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rthe","family":"Jechorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjwal Mukund","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Vasapolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Macke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Aulinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Selgrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41467-019-10050-1","article-title":"Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps","volume":"10","author":"Ailloud","year":"2019","journal-title":"Nat. Commun."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3201\/eid1003.030252","article-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","volume":"10","author":"Albrich","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/mdr.2010.0154","article-title":"Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico","volume":"17","author":"Ayala","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cmi.2019.06.007","article-title":"Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018","volume":"26","author":"Bluemel","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Canton","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle","year":"2010","journal-title":"Gastrointest Endosc."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/31.1.65","article-title":"The E test for antimicrobial susceptibility testing of Helicobacter pylori","volume":"31","author":"Cederbrant","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG Clinical Guideline: Treatment of Helicobacter pylori Infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/AOG.0b013e3181f68086","article-title":"Antimicrobial prophylaxis for cesarean delivery: timing of administration","volume":"116","year":"2010","journal-title":"Obstet Gynecol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0140-6736(75)90498-5","article-title":"A model for gastric cancer epidemiology","volume":"2","author":"Correa","year":"1975","journal-title":"Lancet."},{"key":"ref12","year":"2018"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/BF01960875","article-title":"Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori","volume":"11","year":"1992","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-0042-119653","article-title":"2S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease","volume":"55","author":"Fischbach","year":"2017","journal-title":"Z. Gastroenterol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/jcm.29.9.2072-2075.1991","article-title":"Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori","volume":"29","author":"Glupczynski","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s100960100611","article-title":"European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori","volume":"20","author":"Glupczynski","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1086\/322677","article-title":"Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli","volume":"33","author":"Harbarth","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1046\/j.1523-5378.2003.00145.x","article-title":"Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing","volume":"8","author":"Kim","year":"2003","journal-title":"Helicobacter"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41467-021-22557-7","article-title":"Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides","volume":"12","author":"Kocsm\u00e1r","year":"2021","journal-title":"Nat. Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cpt1978234467","article-title":"Tetracycline absorption in elderly patients with achlorhydria","volume":"23","author":"Kramer","year":"1978","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/1471-0528.12371","article-title":"Are we using too many antibiotics during pregnancy?","volume":"120","author":"Ledger","year":"2013","journal-title":"BJOG."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/jac\/dkv155","article-title":"Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection","volume":"70","author":"Lopez-Gongora","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2147\/DDDT.S136240","article-title":"Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection","volume":"11","author":"Mascellino","year":"2017","journal-title":"Drug. Des. Devel. Ther."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11739-011-0680-x","article-title":"The difficulties of polytherapy: examples from antimicrobial chemotherapy","volume":"6","author":"Mazzei","year":"2011","journal-title":"Intern. Emerg. Med."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/clinids\/5.6.1033","article-title":"Antimicrobial resistance in hospital organisms and its relation to antibiotic use","volume":"5","author":"McGowan","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"Megraud","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","article-title":"The clinical evidence linking Helicobacter pylori to gastric cancer","volume":"3","author":"Moss","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","article-title":"European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients","volume":"70","author":"Nyssen","year":"2021","journal-title":"Gut"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1021\/mp400441d","article-title":"Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions","volume":"10","author":"Pereira","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1469-0691.2005.01099.x","article-title":"Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001","volume":"11","author":"Rimbara","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge","year":"2007","journal-title":"Gut."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e12571","DOI":"10.1111\/hel.12571","article-title":"Gastric cancer prevention targeted on risk assessment: gastritis OLGA staging","volume":"24","author":"Rugge","year":"2019","journal-title":"Helicobacter."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"16245","DOI":"10.3748\/wjg.v20.i43.16245","article-title":"Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection","volume":"20","author":"Selgrad","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrmicro1658","article-title":"Helicobacter pylori evolution and phenotypic diversification in a changing host","volume":"5","author":"Suerbaum","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2169\/internalmedicine.49.3031","article-title":"Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? meta-analysis of randomized controlled trials","volume":"49","author":"Wenzhen","year":"2010","journal-title":"Intern Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jac\/dkp003","article-title":"Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany","volume":"63","author":"Wueppenhorst","year":"2009","journal-title":"J Antimicrob Chemother."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1093\/jac\/dku243","article-title":"Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany","volume":"69","author":"Wuppenhorst","year":"2014","journal-title":"J Antimicrob Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.938676\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:33:47Z","timestamp":1663907627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.938676\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":42,"alternative-id":["10.3389\/fmicb.2022.938676"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.938676","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"938676"}}